Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Nancy Wengenack, Ph.D., director of the Mycology and Microbacteriology Laboratories in Mayo Clinic’s Department of Laboratory Medicine and Pathology, joins the "Answers From the Lab" podcast this week. In this episode, Dr. Wengenack and Bobbi Pritt, M.D., discuss the fungal infection Candida auris.
It’s been understood for some time that an infection of B. mayonii, a rare species of bacterium, results in high levels of spirochetes in the peripheral blood. But actually being able to visualize them on a routine peripheral blood smear may allow for improved recognition of this uncommon cause of Lyme disease.
This week's research roundup features the CLL international prognostic index predicts outcome in monoclonal B-cell lymphocytosis and rai 0 CLL.
Topic's Include: COVID-19 Resource Center addresses surge in delta variant infections, vaccination rates and hot spots, why masking recommendations change, and Mayo Clinic Q&A podcast: The COVID-19 delta variant has changed everything.
Today's highlights include: Marshfield Clinic Health System requiring COVID-19 vaccinations for employees, White House says US had donated 110M Coronavirus vaccine doses abroad, China orders mass testing as COVID outbreak spreads, providers should require COVID vaccinations, masking in schools is the right call, and 5 ways to adjust your sleep schedule when heading back into the office.
In this episode of Lab Medicine Rounds, Justin Juskewitch, M.D., Ph.D., assistant professor of Laboratory Medicine and Pathology at Mayo Clinic, discusses the national blood shortage and why blood inventory is so important.
In August 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., talk about cases of COVID-19 being seen in people who are fully vaccinated and explain why that doesn’t mean the vaccines aren’t working.
In the wake of the CDC withdrawing its emergency use authorization request for a coronavirus PCR test, social media posts claimed the action signaled that the tests were flawed. Dr. Matthew Binnicker explains why those claims are false.
In her role as an education program manager, Heidi Zunker works to bring world-class digital education that’s rooted in Mayo Clinic expertise to thousands of people each year.
This week's research roundup features a risk of late-onset breast cancer in genetically predisposed women.
The following list includes updates posted to mayocliniclabs.com during the month of July.